BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24939249)

  • 1. Pituitary adenylate cyclase-activating polypeptide (PACAP) induces relaxations of peripheral and cerebral arteries, which are differentially impaired by aging.
    Vamos Z; Ivic I; Cseplo P; Toth G; Tamas A; Reglodi D; Koller A
    J Mol Neurosci; 2014 Nov; 54(3):535-42. PubMed ID: 24939249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
    Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
    J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging-Induced Modulation of Pituitary Adenylate Cyclase-Activating Peptide- and Vasoactive Intestinal Peptide-Induced Vasomotor Responses in the Arteries of Mice.
    Ivic I; Solymar M; Fulop BD; Hashimoto H; Toth G; Tamas A; Juhasz T; Koller A; Reglodi D
    J Vasc Res; 2017; 54(6):359-366. PubMed ID: 29131060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VPAC1 receptors play a dominant role in PACAP-induced vasorelaxation in female mice.
    Ivic I; Balasko M; Fulop BD; Hashimoto H; Toth G; Tamas A; Juhasz T; Koller A; Reglodi D; Solymár M
    PLoS One; 2019; 14(1):e0211433. PubMed ID: 30682157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary adenylate cyclase-activating polypeptide ameliorates vascular dysfunction induced by hyperglycaemia.
    Solymar M; Ivic I; Balasko M; Fulop BD; Toth G; Tamas A; Reman G; Koller A; Reglodi D
    Diab Vasc Dis Res; 2018 Jul; 15(4):277-285. PubMed ID: 29466879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PACAP and its receptors in cranial arteries and mast cells.
    Jansen-Olesen I; Hougaard Pedersen S
    J Headache Pain; 2018 Feb; 19(1):16. PubMed ID: 29460121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary adenylate cyclase-activating polypeptide (PACAP) potently dilates middle meningeal arteries: implications for migraine.
    Syed AU; Koide M; Braas KM; May V; Wellman GC
    J Mol Neurosci; 2012 Nov; 48(3):574-83. PubMed ID: 22766684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons.
    Sághy É; Payrits M; Helyes Z; Reglődi D; Bánki E; Tóth G; Couvineau A; Szőke É
    Neuroscience; 2015 Nov; 308():144-56. PubMed ID: 26321242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
    Mounien L; Bizet P; Boutelet I; Gourcerol G; Fournier A; Vaudry H; Jégou S
    Neuroscience; 2006 Nov; 143(1):155-63. PubMed ID: 16962718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenylate cyclase activating polypeptide (PACAP) dilates cerebellar arteries through activation of large-conductance Ca(2+)-activated (BK) and ATP-sensitive (K ATP) K (+) channels.
    Koide M; Syed AU; Braas KM; May V; Wellman GC
    J Mol Neurosci; 2014 Nov; 54(3):443-50. PubMed ID: 24744252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VIP/PACAP receptors in cerebral arteries of rat: characterization, localization and relation to intracellular calcium.
    Erdling A; Sheykhzade M; Maddahi A; Bari F; Edvinsson L
    Neuropeptides; 2013 Apr; 47(2):85-92. PubMed ID: 23375386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat.
    Baun M; Hay-Schmidt A; Edvinsson L; Olesen J; Jansen-Olesen I
    Eur J Pharmacol; 2011 Nov; 670(1):186-94. PubMed ID: 21914446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vasorelaxant effect of pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in isolated rat basilar arteries is partially mediated by activation of nitrergic neurons.
    Seebeck J; Löwe M; Kruse ML; Schmidt WE; Mehdorn HM; Ziegler A; Hempelmann RG
    Regul Pept; 2002 Jul; 107(1-3):115-23. PubMed ID: 12137973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasorelaxant effect of PACAP-27 on canine cerebral arteries and rat intracerebral arterioles.
    Anzai M; Suzuki Y; Takayasu M; Kajita Y; Mori Y; Seki Y; Saito K; Shibuya M
    Eur J Pharmacol; 1995 Oct; 285(2):173-9. PubMed ID: 8566136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the PKA-Bad-14-3-3 signaling pathway in glutamate-induced retinal injury in neonatal rats.
    Rácz B; Gallyas F; Kiss P; Tamás A; Lubics A; Lengvári I; Röth E; Tóth G; Hegyi O; Verzál Z; Fabricsek C; Reglódi D
    Neurotox Res; 2007 Sep; 12(2):95-104. PubMed ID: 17967733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro- and anti-mitogenic actions of pituitary adenylate cyclase-activating polypeptide in developing cerebral cortex: potential mediation by developmental switch of PAC1 receptor mRNA isoforms.
    Yan Y; Zhou X; Pan Z; Ma J; Waschek JA; DiCicco-Bloom E
    J Neurosci; 2013 Feb; 33(9):3865-78. PubMed ID: 23447598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired somatodendritic responses to pituitary adenylate cyclase-activating polypeptide (PACAP) of supraoptic neurones in PACAP type I -receptor deficient mice.
    Jamen F; Alonso G; Shibuya I; Widmer H; Vacher CM; Calas A; Bockaert J; Brabet P; Dayanithi G
    J Neuroendocrinol; 2003 Sep; 15(9):871-81. PubMed ID: 12899682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide and receptors for VIP and PACAP in cutaneous active vasodilation during heat stress in humans.
    Kellogg DL; Zhao JL; Wu Y; Johnson JM
    J Appl Physiol (1985); 2012 Nov; 113(10):1512-8. PubMed ID: 22961270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus.
    Costa L; Santangelo F; Li Volsi G; Ciranna L
    Hippocampus; 2009 Jan; 19(1):99-109. PubMed ID: 18727050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.